New study tests if personalized cholesterol goals beat standard statins for seniors with diabetes

NCT ID NCT07359105

Recruiting now Disease control Sponsor: Sin Gon Kim Source: ClinicalTrials.gov ↗

First seen Jan 23, 2026 · Last updated May 13, 2026 · Updated 18 times

Summary

This study looks at two ways to lower cholesterol in people aged 70 or older who have type 2 diabetes but have never had a heart attack or stroke. One group gets a standard moderate-dose statin, while the other gets treatment aimed at reaching a personalized LDL-cholesterol target. The goal is to see which approach better prevents first-time heart problems, strokes, or death. About 2,186 participants will be followed for several years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA ASSOCIATED WITH TYPE II DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Korea University ANAM Hospital
RECRUITING

Seoul, South Korea
Severance Hospital
NOT_YET_RECRUITING

Seoul, South Korea

Conditions

Explore the condition pages connected to this study.

DYSLIPIDEMIA ASSOCIATED WITH TYPE II DIABETES MELLITUS